HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
4317studies shown
Showing 1,537-1,548 of 4,317
Drug study icon
RecruitingACTRN12623000897662

Estradiol for Eating disorders

Official study title

A double-blinded randomised placebo-controlled trial of estradiol: investigating the effect on disordered eating symptoms of women with anorexia nervosa

In Melbourne
Eating disordersInterventional studyAges 16–60
Countries
Australia
Sponsor
Monash University
Drug study icon
RecruitingACTRN12617001317381

Estrogen for Borderline Personality Disorder/Complex PTSD

What is this study about?

Researchers compare estradiol gel with placebo gel, both alongside usual treatment, in women with borderline personality disorder or complex PTSD. They want to know whether adding this hormone changes symptoms, emotional regulation and thinking skills.

Multiple locations, including Melbourne
Personality disorders, PTSDInterventional studyAges 18–60
Countries
Australia
Sponsor
Alfred Hospital
Device study icon
RecruitingNCT02844049

Deep brain stimulation or medical treatment for resistant OCD

About this title

European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS

Read the official source — NCT02844049
Official study title

European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS Versus Best Medical Treatment

Multiple locations, including Grenoble
OCDDevice studyAges 18–69
Countries
France, Switzerland, Germany, + 1 other
Sponsor
University Hospital, Grenoble
Drug study icon
RecruitingNCT07484204

Single-dose safety of long-acting injectable AX251 in schizophrenia

About this title

Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia

Read the official source — NCT07484204
Official study title

An Open-label, Multicenter Study to Determine the Pharmacokinetics, Safety, and Tolerability of AX251 Long-Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia

Multiple locations, including Ahmedabad
SchizophreniaMedication studyAges 18–65
Countries
India
Sponsor
Anxo Pharmaceutical Co., Ltd.
Other study type icon
RecruitingNCT07389473

Eye movement patterns and prescribed mental health medication use

About this title

Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device

Read the official source — NCT07389473
Official study title

An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device

In Philadelphia
ADHD, Bipolarity, ...Observational studyAges 18–65
Countries
United States
Sponsor
Gaize

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.